Live website intelligence
Arrowhead Pharmaceuticals Home I Arrowhead Pharmaceuticals
Changing the way diseases are treated, Arrowhead pharmaceuticals uses innovative, scientific methods to discover, develop, and deliver therapies and solutions.
Last refresh
Updated 1d ago
Analyst read
Professional
#502.2K global rank5/100 trustHealth & Fitness
Detected stack
WordPress
Quick read
How to read arrowheadpharma.com quickly
arrowheadpharma.com looks like health & fitness. Traffic signals point to roughly 61.8K monthly visits. Current AI trust scoring is 5/100.
What to do next
- The stack appears to include WordPress.
- Open the Traffic tab if you need audience scale and geography before outreach.
- Open the Business tab if trust, monetization, or positioning is your first decision filter.
Provider Completeness
51/56 fields populated (91%)
Providers with missing fields
publisher: 3/5files: 2/3radar: 2/4
View field-level status
visual: 4/4
All expected fields present
meta: 3/3
All expected fields present
seo: 5/5
All expected fields present
dns: 4/4
All expected fields present
ads: 5/5
All expected fields present
publisher: 3/5
Missing: directCount, resellerCount
files: 2/3
Missing: robotsSitemapUrls
traffic: 10/10
All expected fields present
whois: 6/6
All expected fields present
radar: 2/4
Missing: categories, sourceTimestamp
ai: 7/7
All expected fields present
Why this module matters
Business signals help answer “is this a real opportunity?”
Use the business tab to understand trust, monetization, audience fit, and brand posture before you spend time on outreach, partnerships, or competitive teardown work.
- Trust score and sentiment are your first risk screen.
- Business summary and audience notes speed up qualification.
- Ads and monetization patterns reveal how the site captures value.
Business Intelligence
Business Profile
Arrowhead Pharmaceuticals is a biopharmaceutical company developing RNA interference (RNAi) therapeutics to silence disease-causing genes. They recently received FDA approval for Plazarsiran to treat Familial Chylomicronemia Syndrome (FCS).
Business ModelPharmaceutical R&D / Biotech
Target AudiencePatients with genetic diseases, healthcare providers, investors, caregivers, and medical researchers
Classification
CategoryHealth & Fitness
Sub-CategoryPharmaceuticals
biotechnologyRNAigene therapypharmaceuticalsdrug developmentFDA approvalrare diseasestriglyceridesFCS
Trust & Risk
Trust Assessment
Trust Score5/100
SentimentProfessional
Spam DetectionClean
Google Ads Transparency
Is AdvertiserNot Advertising
Ad Count0
no_advertiser_idno_creative_results
Publisher Monetization
ads.txtMissing
Monetization Signals
missing_ads_txt
AI Visual Analysis
Design StyleCorporate Medical
VibeTrustworthy, Innovative, Scientific
UI Score8/100
Detected Logo Textarrowhead pharmaceuticals
IAB Taxonomy
IAB CategoryHealth & Fitness
IAB Sub-CategoryPharmaceuticals
Confidence97%
biotechnologyRNAigene therapypharmaceuticalsdrug developmentFDA approvalrare diseasestriglyceridesFCS
Business Insights
Business Model
Pharmaceutical R&D / Biotech model detected
Trust Level
Low trust with 5/100 score
Audience
Patients with genetic diseases, healthcare providers, investors, caregivers, and medical researchers
Keep exploring
Keep exploring from this report
Good pSEO pages should not strand the visitor. These links keep the journey moving through adjacent directories and comparable live reports.
Need fresh data for another site? Trigger a fresh analysis or open the directory to continue browsing.